<DOC>
	<DOCNO>NCT02905240</DOCNO>
	<brief_summary>A double-blind , multicenter , randomize , control trial ( RCT ) evaluate efficacy single dose Autologous Protein Solution ( APS ) patient Osteoarthritis ( OA ) knee .</brief_summary>
	<brief_title>Saline-Controlled Study nSTRIDE APS Knee Osteoarthritis</brief_title>
	<detailed_description>A double-blind , multicenter , randomize , saline-controlled trial ( RCT ) evaluate efficacy single dose Autologous Protein Solution ( APS ) patient symptomatic osteoarthritis ( OA ) knee able get satisfactory pain relief prior treatment .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Male female ≥ 21 ≤ 80 year old time screen Willingness ability comply study procedure visit schedule ability follow oral write instruction A stand radiograph knee show KellgrenLawrence grade 2 4 absence severe osteoarthritis Body Mass Index ≤ 40 A qualify WOMAC LK 3.1 pain subscale total score Has undergone least one prior conservative osteoarthritis treatment Signed institutional review board approve informed consent Presence clinically observe active infection index knee Presence symptomatic osteoarthritis nonstudy knee Diagnosed rheumatoid arthritis , Reiter 's syndrome , psoriatic arthritis , gout , ankylose spondylitis , arthritis secondary inflammatory disease ; HIV , viral hepatitis ; chondrocalcinosis , Paget 's disease , villonodular synovitis Diagnosed leukemia , know presence metastatic malignant cell , ongoing plan chemotherapeutic treatment Untreated symptomatic injury index knee Presence surgical hardware foreign body intend treat arthritis cartilagerelated pathology index knee Previous cartilage repair procedure injure cartilage surface index knee Arthroplasty open surgery index knee within 6 month screen Intraarticular steroid injection index knee within 3 month screen Intraarticular hyaluronic acid injection index knee within 6 month screen Other intraarticular therapy index knee within 6 month prior screen Orally administer systemic steroid use within 2 week screen Planned/anticipated surgery index knee study period Skin breakdown knee injection plan take place Pregnant nursing mother woman plan get pregnant time participate study Participated investigational drug device trial within 30 day prior screen Participated investigational biologic trial within 60 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Autologous Protein Solution</keyword>
	<keyword>APS</keyword>
	<keyword>intra-articular injection</keyword>
	<keyword>osteoarthritis</keyword>
</DOC>